10-Q: Chicago Atlantic Q2 Net Income Dips Amid Rising Credit Loss Provisions

Chicago Atlantic Real Estate Finance, Inc. reported a 3% decline in Q2 net income to $8.9 million, driven by a significant increase in credit loss provisions, despite growth in net interest income.

Summary

• Net income for the three months ended June 30, 2025, decreased by 3% to $8.9 million, compared to $9.2 million in the prior year period.
• Basic earnings per common share for the quarter was $0.42, down from $0.47 in the same period last year.
• Net interest income increased by 9% to $14.4 million for the quarter, up from $13.2 million.
• Provision for current expected credit losses surged to $1.1 million for the quarter, compared to a benefit of $0.3 million in the prior year.
• Loans held for investment, net, increased to $409.6 million as of June 30, 2025, from $398.1 million at December 31, 2024.
• Two loans, with a carrying value of $22.8 million, were on non-accrual status as of June 30, 2025, up from one loan ($16.4 million) at December 31, 2024.
• The carrying value of loans risk-rated "4" (high risk/potential for loss) increased from 5.4% ($21.6 million) at March 31, 2025, to 9.5% ($39.4 million) at June 30, 2025.
• Weighted-average Yield-to-Maturity Internal Rate of Return (YTM IRR) on the portfolio decreased to 16.8% at June 30, 2025, from 18.7% at June 30, 2024.
• Cash and cash equivalents increased to $35.6 million as of June 30, 2025, from $26.4 million at December 31, 2024.
• The Revolving Loan maturity date was extended from June 30, 2026, to June 30, 2028, in a subsequent event.
• Post-period, from July 1 to August 7, 2025, the company received $56.8 million in full loan repayments and recognized $1.0 million in prepayment fees.

Sentiment

Score: 4

Explanation: While net interest income and distributable earnings showed growth, the decline in GAAP net income and EPS, coupled with a significant increase in credit loss provisions and a rise in high-risk loans, indicates underlying challenges in the loan portfolio's credit quality. The positive subsequent events are encouraging but occurred after the reporting period, and the inherent risks of the cannabis industry persist.

Positives

• Net interest income increased by 9% to $14.4 million for the three months ended June 30, 2025, driven by a $1.5 million increase in fee income, primarily from the refinancing of Loan #7.
• Distributable Earnings (non-GAAP) for the three months ended June 30, 2025, increased to $10.9 million from $9.9 million in the prior year period.
• Cash and cash equivalents significantly increased to $35.6 million as of June 30, 2025, from $26.4 million at December 31, 2024.
• The Revolving Loan maturity was extended by two years to June 30, 2028, providing enhanced liquidity and stability.
• Subsequent to the quarter-end, $56.8 million in principal repayments were received from six loans, including related party loans, generating $1.0 million in prepayment fees.
• The company remains in compliance with all financial covenants for both the Revolving Loan and Unsecured Notes.

Negatives

• Net income for the three months ended June 30, 2025, decreased by 3% to $8.9 million, and basic earnings per common share declined to $0.42 from $0.47.
• The provision for current expected credit losses increased significantly to $1.1 million for the three months ended June 30, 2025, compared to a benefit of $0.3 million in the prior year period.
• The carrying value of loans risk-rated "4" (high risk/potential for loss) increased from 5.4% ($21.6 million) at March 31, 2025, to 9.5% ($39.4 million) at June 30, 2025.
• Two loans, including a newly non-accrual Loan #6 ($4.9 million outstanding principal), were on non-accrual status as of June 30, 2025, totaling $22.8 million in carrying value.
• The weighted-average Yield-to-Maturity Internal Rate of Return (YTM IRR) on the loan portfolio decreased to 16.8% at June 30, 2025, from 18.7% at June 30, 2024, partly due to re-pricing amendments and prime rate decline.
• Real estate collateral coverage for the portfolio decreased to 1.2x as of June 30, 2025, from 1.3x as of June 30, 2024.
• Proceeds from the At-the-Market (ATM) offering program significantly decreased to $1.0 million for the six months ended June 30, 2025, compared to $20.2 million in the same period last year.

Risks

• Federal Illegality of Cannabis: Cannabis remains illegal under U.S. federal law, posing a risk of strict enforcement against borrowers and potential inability to take possession of collateral.
• License Maintenance: Borrowers may be unable to renew or maintain state licenses and other requisite authorizations for their cannabis operations.
• Loan Illiquidity: Loans to cannabis companies may lack liquidity, potentially leading to losses if the company needs to sell a defaulted loan.
• Adverse Law Changes: New state or national laws or enforcement guidelines adverse to cannabis cultivation, production, and distribution could impede business growth.
• Interest Rate Risk: Exposure to fluctuations in interest rates, particularly with floating-rate assets subject to caps and borrowing costs not subject to similar restrictions, could lead to declining net interest spread.
• Interest Rate Mismatch Risk: Potential for increased borrowing costs (Prime Rate/SOFR-based) not being matched by fixed-rate interest earnings or corresponding increases in floating-rate earnings, adversely affecting profitability.
• Credit Risk: Unanticipated credit losses from loans and interest receivables, despite mitigation efforts, could adversely impact operating results.
• Real Estate Risk: Commercial real estate loans are subject to volatility from economic conditions, local market dynamics, and property value decreases, which could reduce collateral value and lead to losses.
• Competition for Capital: Increasing competition for the capital provided to cannabis operating companies could impact future opportunities.
• Reliance on Manager: Operating results depend on the Manager's ability to locate suitable loan opportunities, monitor the portfolio, and implement investment strategy.
• Concentration Risk: The loan portfolio is concentrated, with the top three borrowers representing approximately 25.6% of principal outstanding as of June 30, 2025.

Future Outlook

The company expects continued growth in its loan portfolio, capitalizing on favorable market conditions in the cannabis industry due to an imbalance in supply and demand for credit. It anticipates needing to raise additional equity and/or debt financing to support future investments, primarily through capital recycling from loan paydowns, repayments, and common stock sales via its shelf registration statement and ATM program. The company aims to maintain its REIT qualification and Investment Company Act exemption, and its ability to grow depends on evolving state laws regarding cannabis.

Management Comments

• "We believe that favorable market conditions, including an imbalance in supply and demand of credit to cannabis operating companies, have provided attractive opportunities for non-bank lenders, such as us, to finance commercial real estate loans and other loans that exhibit strong fundamentals but also require more customized financing structures and loan products than regulated financial institutions can presently provide."
• "To be conservative, we have not assumed any prepayment penalties or early payoffs in our estimated YTM calculation. Estimated YTM is based on current management estimates and assumptions, which may change. Actual results could differ from those estimates and assumptions."
• "Management has begun the process to exercise its rights and remedies under the loan documents [for Loan #6, placed on non-accrual]."
• "Management will closely monitor and evaluate the financial and cash flow performance of the now operational assets [related to Loan #9], before restoring Loan #9 to accrual status."
• "We believe that our cash on hand, capacity available under our Revolving Loan, the Unsecured Notes and cash flows from operations for the next twelve months will be sufficient to satisfy the operating requirements of our business through at least the next twelve months."
• "We expect this dataset [historical market loan loss data for commercial real estate loans] to be representative for future credit losses whilst considering that the cannabis industry is maturing, and consumer adoption, demand for production, and retail capacity are increasing akin to commercial real estate over time."

Industry Context

The company operates as a commercial mortgage REIT primarily focused on the U.S. state-licensed cannabis industry, which continues to face a supply-demand imbalance for credit from traditional financial institutions due to federal illegality. This creates a niche for non-bank lenders like Chicago Atlantic. The industry is maturing, with increasing consumer adoption, production demand, and retail capacity, which the company believes is akin to commercial real estate growth over time. However, the inherent federal illegality of cannabis and the evolving state regulatory landscape remain significant industry-specific challenges and risks.

Comparison to Industry Standards

• The company's weighted-average YTM IRR of 16.8% at June 30, 2025, while indicative of high-yield lending, decreased from 18.7% at June 30, 2024. This internal trend suggests a potential shift in portfolio yield or risk profile compared to its own historical performance.
• The real estate collateral coverage for the portfolio decreased to 1.2x as of June 30, 2025, from 1.3x as of June 30, 2024. This internal benchmark indicates a slight reduction in the tangible asset backing of the loans relative to their value over time.
• The increase in loans risk-rated "4" (high risk/potential for loss) from 5.4% ($21.6 million) at March 31, 2025, to 9.5% ($39.4 million) at June 30, 2025, reflects a notable deterioration in the credit quality of a segment of the loan book when compared to the company's own recent past.
• The presence of two non-accrual loans, including a newly identified one (Loan #6), represents a specific credit challenge that deviates from a perfectly performing loan portfolio, a key internal metric for assessing loan quality.
• The company's ability to extend its Revolving Loan maturity to June 30, 2028, is a positive sign of lender confidence, aligning with standard financing practices for established REITs in securing long-term capital.

Corporate Governance

Legal Proceedings

• The company is not aware of any legal claims that could materially impact its business, financial condition, or results of operations as of June 30, 2025.
• The Administrative Agent for Loan #9 was granted a summary judgment of approximately $14.5 million against the borrower credit parties and related individuals in December 2024, which was further supported by a Pennsylvania court order in January 2025.

Related Party Transactions

• Management Agreement: The company is externally managed by Chicago Atlantic REIT Manager, LLC, which receives base management fees and incentive compensation. The agreement was automatically renewed on April 30, 2025.
• Base Management Fee Offset: For the three and six months ended June 30, 2025, the Base Management Fee was reduced by $133,046 and $136,617, respectively, due to Outside Fees earned by the Manager or its affiliates.
• Co-Investment in Loans: The company co-invests with other investment vehicles managed by its affiliates. As of June 30, 2025, 15 of the company's loans were co-invested by affiliates.
• Loans Held for Investment Related Party: Loan #3 and Loan #33, whose borrowers are affiliates of Vireo Growth, Inc. (where the Executive Chairman of the Board serves as CEO and Co-Executive Chairman), were fully repaid subsequent to June 30, 2025.
• Loans Held for Investment Related Party: Loan #9, co-invested by the company and an affiliated investment fund, remains on non-accrual status as of June 30, 2025. Following foreclosure proceedings, the company now holds a $14.5 million Judgment Loan and a $2.0 million Term Loan related to this.
• Loans, at Fair Value Related Party: Loan #39, originated to a subsidiary of Vireo, was fully repaid subsequent to June 30, 2025.

Stakeholder Impact

• Shareholders: Potential for reduced dividends if REIT taxable income decreases or if the company needs to retain more capital. The decline in EPS and book value per share could negatively impact shareholder value. However, consistent dividend payments and subsequent loan repayments provide some stability.
• Employees (of Manager): Continued stock-based compensation and incentive fees, indicating ongoing alignment and reward for performance.
• Borrowers (Cannabis Operators): Continued access to capital from a non-bank lender, which is crucial given the limited traditional financing options. However, increased non-accrual loans and higher risk ratings for some loans indicate financial stress for certain borrowers.
• Creditors (Revolving Loan, Unsecured Notes): The extension of the Revolving Loan maturity and compliance with financial covenants provide reassurance regarding the company's ability to meet its debt obligations.

Next Steps

• Continue to grow the loan portfolio by originating and investing in senior secured loans and alternative structured financings.
• Raise additional equity and/or debt financing to increase liquidity and fund future investments, potentially through the ATM program or other offerings under the Shelf Registration Statement.
• Closely monitor and evaluate the financial and cash flow performance of assets related to Loan #9 before restoring it to accrual status.
• Exercise rights and remedies under loan documents for Loan #6, which is on non-accrual status.
• Continue to monitor the legal landscape pertaining to the cannabis industry to mitigate risks from potential adverse law changes.
• Finalize execution and documentation of augmented internal control procedures related to CECL reporting.

Key Dates

Recommendation

The company exhibits a mixed financial performance for the quarter, with a decline in GAAP net income and EPS, alongside a notable increase in credit loss provisions and a higher proportion of high-risk loans. While net interest income and distributable earnings show growth, and subsequent loan repayments are positive for liquidity, the underlying deterioration in credit quality and the inherent risks of the cannabis industry warrant caution. The extension of the revolving loan maturity is a positive, but the overall picture suggests a period of managing existing challenges rather than strong growth. Therefore, a 'Hold' recommendation is appropriate for investors to monitor the resolution of non-accrual loans and the impact of credit quality trends.

Keywords

REIT, Commercial Mortgage, Cannabis Industry, Real Estate Finance, Loan Portfolio, Credit Risk, Interest Rates, SEC Filing, 10-Q, Financial Results, Dividends, Liquidity, Capital Markets, REFI